{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00499",
      "entity_text" : "beta-AR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:2249",
      "entity_text" : "atenolol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The SHR was treated with beta-AR antagonist atenolol (AT, 10 mg/kg, IV) 5 min before CIR, and NWR were treated with beta-AR agonist isoproterenol (ISO, 0.5 mg/kg, IV) 5 min before CIR.",
  "reading_complete" : "2020-08-05T18:56:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T18:55:11Z",
  "trigger" : "antagonist",
  "evidence" : [ "beta-AR antagonist atenolol" ],
  "pmc_id" : "6583939",
  "score" : 0
}